Filing Details

Accession Number:
0001140361-17-034317
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-05 17:50:51
Reporting Period:
2017-08-31
Accepted Time:
2017-09-05 16:50:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561387 Health Insurance Innovations Inc. HIIQ Insurance Agents, Brokers & Service (6411) 461282634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569128 D Michael Hershberger C/o Health Insurance Innovations, Inc.
15438 North Florida Ave., Suite 201
Tampa FL 33613
Cfo, Secretary And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2017-08-31 2,500 $34.81 94,569 No 4 S Direct
Class A Common Stock Disposition 2017-09-01 400 $28.36 94,169 No 4 S Direct
Class A Common Stock Disposition 2017-09-01 3,300 $29.10 90,869 No 4 S Direct
Class A Common Stock Disposition 2017-09-01 100 $30.45 90,769 No 4 S Direct
Class A Common Stock Disposition 2017-09-01 800 $32.09 89,969 No 4 S Direct
Class A Common Stock Disposition 2017-09-01 400 $33.74 89,569 No 4 S Direct
Class A Common Stock Acquisiton 2017-09-01 15,000 $10.45 104,569 No 4 M Direct
Class A Common Stock Disposition 2017-09-01 4,659 $28.97 99,910 No 4 D Direct
Class A Common Stock Disposition 2017-09-01 3,597 $28.97 96,313 No 4 S Direct
Class A Common Stock Acquisiton 2017-09-01 15,000 $4.95 111,313 No 4 M Direct
Class A Common Stock Disposition 2017-09-01 2,207 $32.02 109,106 No 4 D Direct
Class A Common Stock Disposition 2017-09-01 4,450 $32.02 104,656 No 4 S Direct
Class A Common Stock Acquisiton 2017-09-01 7,500 $4.99 112,156 No 4 M Direct
Class A Common Stock Disposition 2017-09-01 1,113 $33.81 111,043 No 4 D Direct
Class A Common Stock Disposition 2017-09-01 2,222 $33.81 108,821 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2017-09-01 15,000 $0.00 15,000 $10.45
Common Stock Stock Appreciation Rights Disposition 2017-09-01 15,000 $0.00 15,000 $4.95
Common Stock Stock Appreciation Rights Disposition 2017-09-01 7,500 $0.00 7,500 $4.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2021-05-21 No 4 M Direct
15,000 2022-07-01 No 4 M Direct
22,500 2022-09-16 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Appreciation RIghts $5.20 2023-09-16 40,972 40,972 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2023-09-16 40,972 40,972 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.75 to $34.90, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  2. Sale made pursuant to 10b5-1 plan executed on November 18, 2016.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.85 to $28.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.0990, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.65 to $33.80, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  7. These stock-settled stock appreciation rights were granted under the Long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
  8. These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.00, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.15, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.80 to $33.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  12. Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.